Physician profile
April E Callister
NPI 1124861315
$1,587.59
in general payments reported to CMS, 2019-2025
9 companies · $1,560 in 2025
The $1,560 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $27.30 · 2025: $1,560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,059 · Food and Beverage: $529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,059.00 |
| Food and Beverage | $528.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $1,161.61 | 2025 | Vasoview Hemopro 2 |
| Abiomed | $225.99 | 2025 | |
| Ethicon US, LLC | $49.28 | 2025 | Vistaseal, Stratafix |
| Medical Device Business Services, INC. | $40.15 | 2025 | Evarrest |
| Atricure, INC. | $27.30 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.26 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $21.82 | 2025 | Tagrisso |
| Baxter Healthcare | $18.80 | 2025 | Preveleak |
| Octapharma USA, INC. | $18.38 | 2025 | Fibryga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Callister listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.